The first article in this issue of IPR Amicus elaborately discusses a recent Delhi High Court Division Bench decision which revolved around interpretation of ‘enhanced efficacy’ under Section 3(d) of the Patents Act, 1970.

The first article in this issue of IPR Amicus sheds light on the current Indian Patent Law associated with safeguarding Traditional Knowledge. It discusses various case law and the Indian Patent Office’s Guidelines for processing patent...

The article in this issue of IPR Amicus elaborately discusses a recent Madras High Court decision setting aside an order passed by the Assistant Controller of Patents and Designs which had refused the grant of a patent under Section 3(c) of the Patents Act, 1970.

The Division Bench of the Delhi High Court has set aside the Single Bench’s order which had affirmed the Protection of Plant Varieties & Farmers' Rights Authority’s order of revocation of registration.

One of the permissible ways of amendments to claims and/or specification is to incorporate suitable disclaimers during the patent prosecution and at the post grant stage.

There are two discernible facets when a celebrity wants to protect their personality rights: first, the right to protect one’s image from being commercially exploited without permission by treating it as a tort of passing off; mainly termed as publicity rights...

The first article in this issue of IPR Amicus covers a recent decision of the Madhya Pradesh High Court which has held that a suit for infringement of Geographical Indication tags is maintainable...

The article in this issue of IPR Amicus discusses a recent Madras High Court decision against a refusal order for registration of the mark ‘Inimox’ considering an opposition by the owner of mark ‘Imox’...

The article in this issue of IPR Amicus explores the scope of patentability and infringement concerning product-by-process claims with a specific emphasis on the recent two decisions of the Delhi High Court.

Dr. Katalin Kariko and Dr. Drew Weissman have been named the winners of the 2023 Nobel Prize in Physiology and Medicine for their innovations concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.